2021/2718(DEA)
Criteria for the designation of antimicrobials to be reserved for the treatment of certain infections in humans
Basic information
2021/2718(DEA)
DEA - Delegated acts procedure
Supplementing 2014/0257(COD)
Subject
3.10.08 Animal health requirements, veterinary legislation and pharmacy
4.20 Public health
4.60.04.04 Food safety
Status
Procedure completed - delegated act enters into force
Key players
-
European Parliament
Committee responsible Rapporteur Appointed HÄUSLING Martin (Greens/EFA)
17/06/2021
Key events
| Date | Event | Reference | Summary |
|---|---|---|---|
| 10/03/2016 | Matter referred back to the committee responsible | ||
| 26/05/2021 | Non-legislative basic document published | C(2021)03552 | |
| 26/05/2021 | Initial period for examining delegated act 2.0 month(s) | ||
| 09/06/2021 | Committee referral announced in Parliament | ||
| 14/07/2021 | Initial period for examining delegated act extended at Parliament's request by 2.0 month(s) | ||
| 14/10/2021 | Delegated act not objected by Parliament |
Technical information
| Procedure | Information |
|---|---|
| Procedure reference | 2021/2718(DEA) |
| Procedure type | DEA - Delegated acts procedure |
| Nature of procedure | Examination of delegated act |
| Supplementing 2014/0257(COD) | |
| Legal basis | Rules of Procedure EP 114-p03 |
| Stage reached in procedure | Procedure completed - delegated act enters into force |
| Committee dossier |
ENVI/9/06142
|
Documentation gateway
-
Document type Committee Reference Date Summary Motion for a resolution objecting delegated act B9-0424/2021 08/09/2021 -
Document type Reference Date Summary Non-legislative basic document C(2021)03552 26/05/2021